Glucotrack unit to launch GLP-1 patient comparison app in October

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Glucotrack unit to launch GLP-1 patient comparison app in October

Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14

September 30, 2026 9:00 AM EDT

Developed Through ai² Accelerator, Qare Is Designed to Enable Users to Compare Their Experiences Against Cohorts of People Like Them, with Additional Drug Classes Expected to Follow

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced Qare, a comparative health platform designed to evaluate treatment outcomes by comparing experiences across patients using different medications within the same therapeutic class. Introduced on National GLP-1 Day, Qare is expected to become publicly available on October 14, 2026.

Launching initially in the GLP-1... More